CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$0.26 USD
+0.01 (3.43%)
Updated Aug 4, 2025 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CODX 0.26 +0.01(3.43%)
Will CODX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CODX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CODX
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Here's Why You Should Add Cencora Stock to Your Portfolio Now
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates
Concentra Group (CON) Tops Q1 Earnings and Revenue Estimates
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy
Other News for CODX
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast | CODX ...
Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025 | CODX Stock News
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session